Cholesterol Drugs may Lower Cancer-related Deaths in Women

Cholesterol-lowering medication could reduce the death risk for women with breast cancer, colorectal cancer, or melanoma, reports a new study. The findings of the study are published in the British Journal of Clinical Pharmacology.

The analysis included 20,046,11,719 and 6,430 women in Australia who were diagnosed with breast cancer, colorectal cancer, and melanoma, respectively, from 2003 to 2013.

‘Cholesterol-lowering medicines, primarily statins, could be repurposed as adjuvant therapy to improve cancer prognosis. ’

The women had been prescribed cholesterol-lowering medications such as statins before their diagnosis.

The more consistently women took these medications in the year after being diagnosed with cancer, the lower their likelihood of dying from the disease, suggesting that the drugs may have anti-tumor effects.

"If this inverse adherence-response relationship is confirmed, cholesterol-lowering medications could be purposed as adjuvant treatment to improve cancer prognosis," stated co-author Jia-Li Feng, BMed, MMed, PhD, of QIMR Berghofer Medical Research Institute.

Source: Eurekalert